The performance of glycated albumin as a biomarker of hyperglycemia and cardiometabolic risk in children and adolescents in the United States.
Pediatr Diabetes
; 23(2): 237-247, 2022 03.
Article
in En
| MEDLINE
| ID: mdl-34775677
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Serum Albumin
/
Glycation End Products, Advanced
/
Hyperglycemia
Type of study:
Etiology_studies
/
Observational_studies
/
Prevalence_studies
/
Prognostic_studies
/
Risk_factors_studies
Limits:
Adolescent
/
Child
/
Humans
/
Male
Country/Region as subject:
America do norte
Language:
En
Journal:
Pediatr Diabetes
Journal subject:
ENDOCRINOLOGIA
Year:
2022
Document type:
Article
Affiliation country: